- Home
- PCRX vs HSTM Comparison
PCRX vs HSTM Comparison
Compare PCRX & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCRX | HSTM |
|---|---|---|
| Founded | 2006 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2010 | 1999 |
Fundamental Metrics
Financial Performance| Metric | PCRX | HSTM |
|---|---|---|
| Price | $36.40 | $34.71 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 6 |
| Target Price | $33.57 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 2.3M | 158.7K |
| Earning Date | 11-13-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 0.42% |
| EPS Growth | ★ 107.44 | N/A |
| EPS | 0.19 | ★ 0.43 |
| Revenue | ★ $541,533,000.00 | $304,064,000.00 |
| Revenue This Year | $3.84 | $8.35 |
| Revenue Next Year | $4.73 | $4.59 |
| P/E Ratio | $191.58 | ★ $78.35 |
| Revenue Growth | ★ 26.04 | 4.26 |
| 52 Week Low | $18.80 | $19.50 |
| 52 Week High | $36.67 | $35.61 |
Technical Indicators
Market Signals| Indicator | PCRX | HSTM |
|---|---|---|
| Relative Strength Index (RSI) | 83.12 | 66.85 |
| Support Level | $21.97 | $27.77 |
| Resistance Level | $36.45 | $35.61 |
| Average True Range (ATR) | 0.09 | 0.92 |
| MACD | -0.28 | -0.11 |
| Stochastic Oscillator | 25.35 | 69.17 |
Price Performance
Historical ComparisonAbout PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About HSTM HealthStream Inc.
HealthStream Inc provides SaaS based applications for healthcare organizations all designed to improve business and clinical outcomes by supporting the people who deliver patient care. The company is focused on helping individuals and organizations in healthcare meet their ongoing learning, clinical development, credentialing, and scheduling needs. It also provides its solutions to nursing schools and nursing students.